Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancer

International Journal of Cancer

Volumn 77, Issue 1, 1998, Pages 13-18

  Van Gog, Frank B ^a   Brakenhoff, Ruud H ^a   Stigter van Walsum, Marijke ^a   Snow, Gordon B ^a   Van Dongen, Guus A M S ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY 425; MONOCLONAL ANTIBODY E48; MONOCLONAL ANTIBODY U36; RHENIUM 186; UNCLASSIFIED DRUG;

ARTICLE; HEAD AND NECK CANCER; IMMUNOSCINTIGRAPHY; NUDE MOUSE; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; SQUAMOUS CELL CARCINOMA; TUMOR DIAGNOSIS; TUMOR REGRESSION; XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; MICE; MICE, NUDE; NEOPLASM, RESIDUAL; NEOPLASMS, EXPERIMENTAL; RADIOIMMUNOTHERAPY; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 0032479275     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980703)77:1<13::AID-IJC3>3.0.CO;2-2     Document Type: Article

References (22)

1. ABOUD-PIRAK, E., HURWITZ, E., PIRAK, M.E., BELLOT, F., SCHLESSINGER, J. and SELA, M., Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice. J. nat. Cancer Inst., 80, 1605-1611 (1988).
2. BASELGA, J., NORTON, L., MASUI, H., PANDIELLA, A., COPLAN, K., MILLER, W.H. Jr. and MENDELSOHN, J., Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. J. nat. Cancer Inst., 85, 1327-1333 (1993).
3. 125labeled monoclonal antibody 425 to epidermal growth factor receptor. Cancer Res., 52, 121-126 (1992).
4. BIER, H., REIFFEN, K.A., HAAS, I. and STASIECKI, P., Dose-dependent access of murine anti-epidermal growth factor receptor monoclonal antibody to tumor cells in patients with advanced laryngeal and hypopharyngeal carcinoma. Europ. Arch. Otorhinol., 252, 433-439 (1995).
5. DE BREE, R., ROOS, J.C., QUAK, J.J., DEN HOLLANDER, W., SNOW, G.B. and VAN DONGEN, G.A.M.S., Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer. Clin. Cancer. Res., 1, 591-598 (1995a).
6. 2 in patients with head and neck cancer. Clin. Cancer Res., 1, 277-286 (1995B).
7. DENARDO, S.J., GUMERLOCK, P.H., WINTHROP, M.D., MACK, P.C., CHI, S.G., LAMBORN, K.R., SHEN, S., MIERS, L.A., DEVERE WHITE, R.W. and DENARDO, G.L., Yttrium-90 chimeric L6 therapy of human breast cancer in nude mice and apoptosis-related messenger RNA expression. Cancer Res., 55, 5837s-5841s (1995).
8. DIVGI, C.R., WELT, S., KRIS, M., REAL, F.X., YEH, S.D., GRALLA, R., MERCHANT, B., SCHWEIGHART, S., UNGER, M., LARSON, S.M. and MENDELSOHN, J., Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma. J. nat. Cancer Inst., 83, 97-104 (1991).
9. FAN, Z., BASELGA, J., MASUI, H. and MENDELSOHN, J., Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cisdiamminedichloroplatinum on well established A431 cell xenografts. Cancer Res., 53, 4637-4642 (1993).
10. GERRETSEN, M., VISSER, G.W.M, BRAKENHOFF, R.H., VAN WALSUM, M., SNOW, G.B. and VAN DONGEN, G.A.M.S., Complete ablation of small squamous cell carcinoma xenografts with 186Re-labeled monoclonal antibody E48. Cell. Biophysics, 24, 135-142 (1994).
11. 186Re-labeled monoclonal antibody E48 IgG mediated therapy of human head and neck squamous cell carcinoma xenografts. Cancer Res., 53, 3524-3529 (1993).
12. GRANDIS, J.R., MELHEM, M.F., BARNES, E.L. and TWEARDY, D.J., Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer, 78, 1284-1292 (1996).
13. MACKLIS, R.M., BERESFORD, B.A. and HUMM, J.L., Radiobiologic studies of low-dose-rate 90Y-lymphoma therapy. Cancer, 73, 966-973 (1994).
14. MODJTAHEDI, H. and 13 OTHERS, Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer. Brit. J. Cancer., 73, 228-235 (1996).
15. PEREZ-SOLER, R., DONATO, N.J., SHIN, D.M., ROSENBLUM, M.G., ZHANG, H.Z., TORNOS, C., BREWER, H., CHAN, J.C., LEE, J.S., HONG, W.K. and MURRAY, J.L., Tumor epidermal growth factor receptor studies in patients with non-small-cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852. J. clin. Oncol., 12, 730-739 (1994).
16. RODECK, U., HERLYN, M., HERLYN, D., MOLTHOFF, C., ATKINSON, B., VARELLO, M., STEPLEWSKI, Z. and KOPROWSKI, H., Tumor growth modulation by an antibody to the epidermal growth factor receptor: immunologically mediated and effector cell-independent effects. Cancer Res., 47, 3692-3696 (1987).
17. SCHNURCH, H.G., STEGMULLER, M., VERING, A., BECKMANN, M.W. and BENDER, H.G., Growth inhibition of xenotransplanted human carcinomas by a monoclonal antibody directed against the epidermal growth factor receptor. Europ. J. Cancer., 30A, 491-496 (1994).
18. SENEKOWITCH-SMIDTKE, R., STEINER, K., HAUNSCHILD, J., MOELLENSTAEDT, S. and TRUCKENBRODT, R., In vivo evaluation of epidermal growth factor (EGF) receptor density on human tumor xenografts using radiolabeled EGF and anti-(EGF receptor) mAb 425. Cancer Immunol. Immunother., 42, 108-114 (1996).
19. STRAGLIOTTO, G., VEGA, F., STASIECKI, P., GROPP, P., POISSON, M. and DELATTRE, J.-Y., Multiple infusions of anti-epidermal growth factor receptor (EGFR) monoclonal antibody (HMD 55900) in patients with recurrent malignant gliomas. Europ. J. Cancer, 32A, 636-640 (1996).
20. 186Re-labeling of monoclonal antibodies for clinical application: pitfalls and solutions. Cancer, 80, 2360-2370 (1997).
21. VAN HAL, N.L.W., VAN DONGEN, G.A.M.S., ROOD-KNIPPELS, E.M.C., VAN DER VALK, P., SNOW, G.B. and BRAKENHOFF, R.H., Monoclonal antibody U36, a suitable candidate for clinical immunotherapy of squamous-cell carcinoma, recognizes a CD44 isoform. Int. J. Cancer, 68, 520-527 (1996).
22. WU, X., FAN, Z., MASUI, H., ROSEN, N. and MENDELSOHN, J., Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. J. clin. Invest., 95, 1897-1905 (1995).